An examination of how medical devices are developed, regulated, and brought to market. The session highlights how clinical impact, usability, reimbursement, and cost structure influence adoption, scalability, and investor returns.

A look at how diagnostics and BioTools companies create value by enabling faster, more accurate insights across clinical care and research. Key drivers include biomarker relevance, throughput, regulatory pathways, and...

A recurring, peer-to-peer gathering for investors and capital partners to have thoughtful conversations about markets, portfolio strategy, emerging sectors, and capital deployment.

An exploration of how software and data-driven solutions are reshaping healthcare delivery, research, and operations. The session distinguishes digital health, health tech, and tech bio, while highlighting how integration, user...

A recurring, peer-to-peer gathering for investors and capital partners to have thoughtful conversations about markets, portfolio strategy, emerging sectors, and capital deployment.

A recurring, peer-to-peer gathering for investors and capital partners to have thoughtful conversations about markets, portfolio strategy, emerging sectors, and capital deployment.

A recurring, peer-to-peer gathering for investors and capital partners to have thoughtful conversations about markets, portfolio strategy, emerging sectors, and capital deployment.

A recurring, peer-to-peer gathering for investors and capital partners to have thoughtful conversations about markets, portfolio strategy, emerging sectors, and capital deployment.